
23andMe's breast cancer test may create false sense of security
7 March 2018
Genomics firm 23andMe is the first to receive approval for direct-to-consumer cancer gene tests in the US, but will recipients misunderstand the results?

7 March 2018
Genomics firm 23andMe is the first to receive approval for direct-to-consumer cancer gene tests in the US, but will recipients misunderstand the results?

10 January 2018
The device lengthens the oesophagus so its two ends can be stitched back together, improving life for children with a birth defect called oesophageal atresia